{"id":"W2167921436","doi":"10.1093/annonc/mdp392","title":"Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Gemcitabine; Internal medicine; Oncology; Lung cancer; Population; Cisplatin; Performance status; Predictive marker; Hazard ratio; Chemotherapy; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003591998,0.0002143972,0.00137899,0.0003558156,0.00003769004,0.000006575277,0.00006137989,0.0001343678,0.00003738813],"category_scores_gemma":[0.0003427072,0.0001742519,0.0001165049,0.0003554654,0.00009383707,0.0001038787,0.00002397942,0.0002139666,4.298189e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001667341,"about_ca_system_score_gemma":0.0004905981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005284466,"about_ca_topic_score_gemma":0.0005601645,"domain_scores_codex":[0.998368,0.0001269563,0.0007046413,0.0003203941,0.0001491596,0.000330869],"domain_scores_gemma":[0.9983503,0.0009260555,0.0003287916,0.0001383407,0.0001323407,0.0001241931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9277024,0.002994896,0.0440722,0.00009811151,0.0004205469,0.00009338477,0.004716252,0.0006554467,0.0009167041,0.00005244536,0.0001232465,0.01815432],"study_design_scores_gemma":[0.941119,0.007782956,0.04087431,0.0002744377,0.0006521536,0.000002128541,0.0006149355,0.007463851,0.0009474491,0.00004838384,0.00007673319,0.0001436278],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890953,0.001373792,0.0001037168,0.0006345714,0.0002827275,0.003422485,0.00002809576,0.00001702512,0.005042346],"genre_scores_gemma":[0.9983941,0.0005311293,0.0003584955,0.0001335838,0.00006244005,0.0003452397,0.00009348269,0.0000132775,0.00006827006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0180107,"threshold_uncertainty_score":0.7105786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05359093777156162,"score_gpt":0.432315294743741,"score_spread":0.3787243569721794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}